The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity
Open accessAbstract
Background: Celiac disease (CD) is an autoimmune enteropathy triggered by the ingestion of gluten. Gluten-sensitive individuals (GS) cannot tolerate gluten and may develop gastrointestinal symptoms similar to those in CD, but the overall clinical picture is generally less severe and is not accompanied by the concurrence of tissue transglutaminase autoantibodies or autoimmune comorbidities. By studying and comparing mucosal expression of genes associated with intestinal barrier function, as well as innate and adaptive immunity in CD compared with GS, we sought to better understand the similarities and differences between these two gluten-associated disorders. Methods: CD, GS and healthy, gluten-tolerant individuals were enrolled in this study. Intestinal permeability was evaluated using a lactulose and mannitol probe, and mucosal biopsy specimens were collected to study the expression of genes involved in barrier function and immunity. Results: Unlike CD, GS is not associated with increased intestinal permeability. In fact, this was significantly reduced in GS compared with controls (P = 0.0308), paralleled by significantly increased expression of claudin (CLDN) 4 (P = 0.0286). Relative to controls, adaptive immunity markers interleukin (IL)-6 (P = 0.0124) and IL-21 (P = 0.0572) were expressed at higher levels in CD but not in GS, while expression of the innate immunity marker Toll-like receptor (TLR) 2 was increased in GS but not in CD (P = 0.0295). Finally, expression of the T-regulatory cell marker FOXP3 was significantly reduced in GS relative to controls (P = 0.0325) and CD patients (P = 0.0293). Conclusions: This study shows that the two gluten-associated disorders, CD and GS, are different clinical entities, and it contributes to the characterization of GS as a condition associated with prevalent gluten-induced activation of innate, rather than adaptive, immune responses in the absence of detectable changes in mucosal barrier function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some patients with IBS lack tissue transglutaminase antibodies or histological markers of coeliac disease yet still respond symptomatically to a gluten-free diet.”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [158]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, P. H. R., & Jones, R. (2006) · Cited by 2,453
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154 · cited 1×
“Different combinations of TLRs are expressed in hematopoietic cells and nonhematopoietic cells such as intestinal epithelial cells [42-44].”
BackgroundFuruse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,095 · cited 2×
“For instance, CLDN1 and CLDN4 are postulated to decrease, whereas CLDN2 is postulated to increase TJ-dependent permeability [35].”
BackgroundIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 1×
“This involves the mucosal recruitment and activation of Th1 and Th17 clones and the production of Th1- and Th17-associated cytokines, namely, IFN-g and IL-17A, which contribute to disrupting barrier function and initiating tissue damage [16,18-21,41].”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542 · cited 7×
“Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.”
BackgroundInfluentialSteinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376 · cited 2×
“This involves the mucosal recruitment and activation of Th1 and Th17 clones and the production of Th1- and Th17-associated cytokines, namely, IFN-γ and IL17A, which contribute to disrupting barrier function and initiating tissue damage [16, 18-21, 41].”
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150 · cited 1×
“Different combinations of TLRs are expressed in hematopoietic cells and nonhematopoietic cells such as intestinal epithelial cells [42-44].”
BackgroundAlterations in intestinal permeability
Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 634 · cited 1×
“Increased intestinal permeability is thought to be an early biological change that precedes the onset of several autoimmune diseases [32-34].”
BackgroundVan Itallie, C., Rahner, C., & Anderson, J. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12464 · Cited by 601 · cited 1×
“associated with marked differences in mucosal barrier function and with apparent differences in the expression of CLDN4, which encodes for a critical TJ component [38].”
BackgroundBrandtzaeg, P., Halstensen, T. S., Kett, K., Krajči, P., Kvale, D., Rognum, T. O., Scott, H., & Sollid, L. M. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90406-x · Cited by 550 · cited 1×
“These are generally defined as gluten sensitivity (GS) [2-5].”
Background
Cited by
The Oslo definitions for coeliac disease and related terms
Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301346 · Cited by 1,721
Self-citationMedicine & science in sports & exercise
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92575-5 · Cited by 1,303
Spectrum of gluten-related disorders: consensus on new nomenclature and classification
Sapone, A., Bai, J. C., Ciacci, C., Dolinsek, J., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Rostami, K., Sanders, D. S., Schumann, M., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-13 · Cited by 1,140
“Therefore, it is not surprising that during the past 50 years we have witnessed an ‘epidemic’ of CD [68,69] and the surging of new gluten-related disorders, including the most recently described GS [44,62].”
BackgroundSelf-citationIntestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Human Intestinal Barrier Function in Health and Disease
König, J., Wells, J., Cani, P. D., García-Ródenas, C. L., MacDonald, T., Mercenier, A., Whyte, J., Troost, F., & Brummer, R.-J. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.54 · Cited by 780
“Sapone et al.126 did not find an increased intestinal permeability in the small bowel Clinical and Translational Gastroenterology of non-celiac gluten-sensitive individuals (n= 13) using the lactulose/mannitol test compared with dyspeptic controls (n=14), whereas celiac disease patients (n= 11) had a significantly inc…”
BackgroundInfluential
Metadata
- Authors
- Sapone, A., Lammers, K. M., Casolaro, V., Cammarota, M., Giuliano, M. T., De Rosa, M., Stefanile, R., Mazzarella, G., Tolone, C., Russo, M. I., Esposito, P., Ferraraccio, F., Cartenì, M., Riegler, G., de Magistris, L., & Fasano, A.
- Affiliations
- University of Maryland, Baltimore (US)
- University of Campania "Luigi Vanvitelli" (IT)
- Institute of Food Science (IT)
- Corresponding author
- Fasano, Alessio
- ORCID
- Venue
- BMC Medicine
- Published
- 2011-03-09
- Volume
- 9
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC3065425
- OpenAlex
- W2069634861
- Cited by
- 452
- References
- 48
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 11 · 2023: 8 · 2022: 20 · 2021: 36 · 2020: 36 · 2019: 35 · 2018: 31 · 2017: 39 · 2016: 36 · 2015: 58 · 2014: 39 · 2013: 38 · 2012: 30
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK078699)
- Topics
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Wheat and Barley Genetics and Pathology
- Keywords
- celiac disease, gluten sensitivity, intestinal permeability, intestinal barrier function, mucosal gene expression, claudin-4, interleukin-6, IL-21, TLR2, Foxp3, regulatory T cells, innate immunity, adaptive immunity, gluten
- MeSH terms
- Adult, Allergens, Celiac Disease, Female, Glutens, Humans, Hypersensitivity, Intestinal Mucosa, Male, Permeability, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. https://app.cochat.ai/papers/10.1186/1741-7015-9-23
- The paper
- Sapone, A., Lammers, K. M., Casolaro, V., Cammarota, M., Giuliano, M. T., De Rosa, M., Stefanile, R., Mazzarella, G., Tolone, C., Russo, M. I., Esposito, P., Ferraraccio, F., Cartenì, M., Riegler, G., de Magistris, L., & Fasano, A. (2011). Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Medicine. https://doi.org/10.1186/1741-7015-9-23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.